APC/Cyanine7 Anti-Mouse/human CD45R/B220 Antibody
英诺赛图(InnoCyto)的 APC/Cyanine7 Anti-Mouse/human CD45R/B220 Antibody(克隆 RA3-6B2) 为大鼠源 IgG2a 单克隆抗体,靶向 CD45R(别名 B220),APC/Cyanine7 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥1,015 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 APC/Cyanine7 Anti-Mouse/human CD45R/B220 Antibody(克隆 RA3-6B2) 为大鼠源 IgG2a 单克隆抗体,靶向 CD45R(别名 B220),APC/Cyanine7 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥1,015 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
200915 | 25 μg | ¥1,015
200916 | 100 μg | ¥2,235
Product Details
Regulatory Status|RUO
Protein Concentration|Supplied at a lot-specific concentration.
Storage & Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended Usage|For flow cytometric staining, it is recommended to use less than 0.3 μg of this reagent per 0.5-1.0 million cells in a 100 μL volume. Optimal reagent performance should be determined by titration for each specific application. APC/Cyanine7 has an excitation max at 650 nm and an emission max at 774 nm.
See All Formats|Clone RA3-6B2
Background Information
CD45R/B220 is a widely used immunological marker that represents a specific isoform of the protein tyrosine phosphatase CD45 (PTPRC). B220 is most commonly associated with B lymphocytes, particularly in mice, where it is expressed throughout much of B cell development and maturation. While B220 is often referred to as a “B cell marker,” it is also expressed on subsets of activated T cells, dendritic cells, and certain leukemic populations, reflecting its role in immune regulation rather than lineage restriction.
Structurally, CD45R/B220 is a type I transmembrane glycoprotein generated through alternative splicing of the CD45 extracellular domain. The B220 isoform includes exon A and produces a high–molecular weight extracellular region compared with other CD45 isoforms such as CD45RO. Like all CD45 family members, B220 contains a single transmembrane domain and a cytoplasmic tail with two protein tyrosine phosphatase domains, of which the membrane-proximal domain is catalytically active. The extracellular domain is heavily glycosylated, contributing to its size and antibody recognition.
CD45R/B220 does not bind a classical extracellular ligand. Instead, its primary function is enzymatic, regulating signaling thresholds in immune cells. In B cells, B220 modulates B cell receptor (BCR) signaling by dephosphorylating Src family kinases such as Lyn, thereby fine-tuning activation, survival, and tolerance. Through this activity, CD45R/B220 ensures that B cells respond appropriately to antigen stimulation while limiting aberrant activation.
CD45R/B220 plays important roles in disease. Altered expression of B220 is observed in autoimmune models, where dysregulated B cell signaling contributes to loss of tolerance and autoantibody production. In murine models of lupus-like disease, abnormal B220 expression is associated with expanded populations of atypical B cells. B220 is also a key diagnostic marker in hematologic malignancies, particularly B cell leukemias and lymphomas, where it aids in immunophenotypic classification. Additionally, aberrant B220 expression on T cells can be a feature of lymphoproliferative disorders.
Therapeutically, CD45R/B220 is primarily used as a biomarker and experimental tool rather than a direct drug target. Antibodies against B220 are routinely employed to identify, isolate, or deplete B cells in research and preclinical studies. In translational contexts, targeting CD45 isoforms, including B220-expressing cells, has been explored in conditioning regimens for bone marrow transplantation and in antibody-based approaches for hematologic disease, highlighting its enduring importance in immunology.
Data Sheets
BALB/c Mouse splenocytes were stained with APC/Cy7 Anti-Mouse/Human CD45R/B220 clone RA3-6B2 (color-filled histogram) or an isotype control (gray histogram).
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). APC/Cyanine7 Anti-Mouse/human CD45R/B220 Antibody(200915)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/apc-cyanine7-anti-mouse-human-cd45r-b220-antibody.html.
TeleVM. (2026, November 12). APC/Cyanine7 Anti-Mouse/human CD45R/B220 Antibody(200915). 产品目录. https://www.suprotek.cn/products/item/apc-cyanine7-anti-mouse-human-cd45r-b220-antibody.html
@misc{biocsp_item_apc_cyanine7_anti_mouse_human_cd45r_b220_antibody,
title = {APC/Cyanine7 Anti-Mouse/human CD45R/B220 Antibody(200915)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/apc-cyanine7-anti-mouse-human-cd45r-b220-antibody.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源